Mumbai: On November 08, 2012, Sun Pharma will announce results for the second
quarter & half year ending September 30, 2012 . These results will also be available on the Company website, www.sunpharma.com.
Earnings call (10.00 am IST, November 09, 2012)
The Company will conduct an hour long call at 10 am IST on November 09, 2012 where senior management will discuss the Company’s performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.
Summary of events
Event Date and time Telephone number/ website
Earnings release November 08, 2012 www.sunpharma.com
Earnings conference call 10.00 am IST, November 09, 2012
Primary Number : +91 22 6629 0088
Secondary Number : +91 22 3065 0088
Via audio webcast, details of which will be made available on www.sunpharma.com.
Replay of conference call November 09, 2012 to November 14, 2012
India : +91 22 3065 1212.
ID: #786742
Via audio webcast playback, details of which will be made available on www.sunpharma.com.
About Sun Pharmaceutical Industries Ltd.
Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India , US and several other markets across the world. In India , the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com .
Sun Pharmaceutical Industries Ltd.
17/B, Mahal Industrial Estate,
Mahakali Caves Road
Andheri (East), Mumbai 400 093 India
Tel.: (91-22) 6645 5645
Fax.: (91-22) 6645 5685
Registered Office : SPARC, Tandalja, Vadodara – 390 020. India
Corporate Office : Acme Plaza , Andheri – Kurla Road , Andheri (East), Mumbai – 400 059. India
Contacts
Mira Desai
Tel +91 22 6645 5645, Xtn 606
Tel Direct +91 22 66455606
Mobile +91 98219 23797
E mail mira.desai@sunpharma.com
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…